These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer. Fendler WP; Philippe Tiega DB; Ilhan H; Paprottka PM; Heinemann V; Jakobs TF; Bartenstein P; Hacker M; Haug AR J Nucl Med; 2013 Aug; 54(8):1202-8. PubMed ID: 23729697 [TBL] [Abstract][Full Text] [Related]
23. Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization. Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Bartenstein P; Hacker M; Haug AR J Nucl Med; 2015 Mar; 56(3):333-8. PubMed ID: 25655623 [TBL] [Abstract][Full Text] [Related]
24. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503 [TBL] [Abstract][Full Text] [Related]
25. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996 [TBL] [Abstract][Full Text] [Related]
26. Comparison of 3 Different Therapeutic Particles in Radioembolization of Locally Advanced Intrahepatic Cholangiocarcinoma. Wagemans MEHM; Kunnen B; Stella M; van Rooij R; Smits M; Bruijnen R; Lam MGEH; de Jong HWAM; Braat AJAT J Nucl Med; 2024 Feb; 65(2):272-278. PubMed ID: 38176716 [TBL] [Abstract][Full Text] [Related]
27. Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT. Lam MG; Goris ML; Iagaru AH; Mittra ES; Louie JD; Sze DY J Nucl Med; 2013 Dec; 54(12):2055-61. PubMed ID: 24144563 [TBL] [Abstract][Full Text] [Related]
28. Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086 [TBL] [Abstract][Full Text] [Related]
29. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Struycken L; Patel M; Kuo P; Hennemeyer C; Woodhead G; McGregor H AJR Am J Roentgenol; 2022 Apr; 218(4):728-737. PubMed ID: 34704460 [No Abstract] [Full Text] [Related]
30. Early metabolic response assessment of breast cancer liver metastases: 4-week posttreatment FDG PET predicts survival after 90Y microsphere radioembolization. Sabet A; Ries M; Al-Khalaf Y; Meyer C; Rudlowski C; Simon B; Khreish F; Ezziddin S Nuklearmedizin; 2019 Jun; 58(3):242-248. PubMed ID: 31167272 [TBL] [Abstract][Full Text] [Related]
31. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization. Abuodeh Y; Naghavi AO; Ahmed KA; Venkat PS; Kim Y; Kis B; Choi J; Biebel B; Sweeney J; Anaya DA; Kim R; Malafa M; Frakes JM; Hoffe SE; El-Haddad G World J Gastroenterol; 2016 Dec; 22(47):10406-10414. PubMed ID: 28058021 [TBL] [Abstract][Full Text] [Related]
33. Feasibility of imaging Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282 [TBL] [Abstract][Full Text] [Related]
34. 99mTc-MAA/ 90Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization. Ahmadzadehfar H; Sabet A; Muckle M; Wilhelm K; Reichmann K; Biersack HJ; Ezziddin S Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1281-8. PubMed ID: 21359611 [TBL] [Abstract][Full Text] [Related]
35. Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization? Burgmans MC; Too CW; Kao YH; Goh AS; Chow PK; Tan BS; Tay KH; Lo RH Eur J Radiol; 2012 Dec; 81(12):3979-84. PubMed ID: 22954411 [TBL] [Abstract][Full Text] [Related]
36. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Flamen P; Vanderlinden B; Delatte P; Ghanem G; Ameye L; Van Den Eynde M; Hendlisz A Phys Med Biol; 2008 Nov; 53(22):6591-603. PubMed ID: 18978442 [TBL] [Abstract][Full Text] [Related]
37. Repeated Treatment with Filippi L; Di Costanzo GG; Tortora R; Pelle G; Cianni R; Schillaci O; Bagni O Cancer Biother Radiopharm; 2019 May; 34(4):231-237. PubMed ID: 30758985 [No Abstract] [Full Text] [Related]
38. Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization. Cheng B; Villalobos A; Sethi I; Wagstaff W; Galt J; Brandon D; Schuster DM; Bercu Z; Majdalany B; Kokabi N Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1194-1203. PubMed ID: 33890170 [TBL] [Abstract][Full Text] [Related]